82 FR 35547 - Importer of Controlled Substances Application: Sigma-Aldrich International GMBH
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 82, Issue 145 (July 31, 2017)
Drug Enforcement Administration
Federal Register Volume 82, Issue 145 (July 31, 2017)
| Page Range | 35547-35548 | |
| FR Document | 2017-16059 |
[Federal Register Volume 82, Number 145 (Monday, July 31, 2017)] [Notices] [Pages 35547-35548] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-16059] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: Sigma-Aldrich International GMBH ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 30, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 30, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007). SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix of subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on January 19, 2016, Sigma-Aldrich International GMBH, Sigma Aldrich Co. LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118 applied to be registered as an importer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Cathinone.......................... 1235 I Methcathinone...................... 1237 I Mephedrone (4-Methyl-N- 1248 I methylcathinone). N-Ethylamphetamine................. 1475 I Aminorex........................... 1585 I Gamma Hydroxybutyric Acid.......... 2010 I [[Page 35548]] Methaqualone....................... 2565 I Alpha-ethyltryptamine.............. 7249 I Ibogaine........................... 7260 I Lysergic acid diethylamide......... 7315 I Marihuana.......................... 7360 I Tetrahydrocannabinols.............. 7370 I Mescaline.......................... 7381 I 4-Bromo-2,5-dimethoxyamphetamine... 7391 I 4-Bromo-2,5-dimethoxyphenethylamine 7392 I 4-Methyl-2,5-dimethoxyamphetamine.. 7395 I 2,5-Dimethoxyamphetamine........... 7396 I 3,4-Methylenedioxyamphetamine...... 7400 I N-Hydroxy-3,4- 7402 I methylenedioxyamphetamine. 3,4-Methylenedioxy-N- 7404 I ethylamphetamine. 3,4-Methylenedioxymethamphetamine.. 7405 I 4-Methoxyamphetamine............... 7411 I Bufotenine......................... 7433 I Diethyltryptamine.................. 7434 I Dimethyltryptamine................. 7435 I Psilocybin......................... 7437 I Psilocyn........................... 7438 I 1-[1-(2- 7470 I Thienyl)cyclohexyl]piperidine. N-Benzylpiperazine................. 7493 I MDPV (3,4- 7535 I Methylenedioxypyrovalerone). Butylone........................... 7541 I Heroin............................. 9200 I Normorphine........................ 9313 I Etonitazene........................ 9624 I Amobarbital........................ 2125 II Pentobarbital...................... 2270 II Secobarbital....................... 2315 II Glutethimide....................... 2550 II Nabilone........................... 7379 II Phencyclidine...................... 7471 II Diphenoxylate...................... 9170 II Ecgonine........................... 9180 II Ethylmorphine...................... 9190 II Levorphanol........................ 9220 II Meperidine......................... 9230 II Thebaine........................... 9333 II Opium, powdered.................... 9639 II Levo-alphacetylmethadol............ 9648 II ------------------------------------------------------------------------ The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. Dated: July 24, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017-16059 Filed 7-28-17; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices 35547
Morrissette Drive, Springfield, Virginia SUPPLEMENTARY INFORMATION: The revocation of registration) has been
22152. All requests for hearing must be Attorney General has delegated his redelegated to the Assistant
sent to: Drug Enforcement authority under the Controlled Administrator of the DEA Diversion
Administration, Attn: Administrator, Substances Act to the Administrator of Control Division (‘‘Assistant
8701 Morrissette Drive, Springfield, the Drug Enforcement Administration Administrator’’) pursuant to section 7 of
Virginia 22152. All request for hearing (DEA), 28 CFR 0.100(b). Authority to 28 CFR part 0, appendix to subpart R.
should also be sent to: (1) Drug exercise all necessary functions with In accordance with 21 CFR
Enforcement Administration, Attn: respect to the promulgation and 1301.34(a), this is notice that on March
Hearing Clerk/LJ, 8701 Morrissette implementation of 21 CFR part 1301, 7, 2017, R & D Systems, Inc., Bio-
Drive, Springfield, Virginia 22152; and incident to the registration of Techne, 614 McKinley Place NE.,
(2) Drug Enforcement Administration, manufacturers, distributors, dispensers, Minneapolis, Minnesota 55413 applied
Attn: DEA Federal Register importers, and exporters of controlled to be registered as an importer of the
Representative/DRW, 8701 Morrissette substances (other than final orders in following basic classes of controlled
Drive, Springfield, Virginia 22152. connection with suspension, denial, or substances:
Controlled substance Drug code Schedule
Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. 7118 I
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ 7297 I
Marihuana ........................................................................................................................................................................ 7360 I
Tetrahydrocannabinols .................................................................................................................................................... 7370 I
4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 7391 I
3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I
Dimethyltryptamine .......................................................................................................................................................... 7435 I
Psilocyn ........................................................................................................................................................................... 7438 I
Pentobarbital .................................................................................................................................................................... 2270 II
Phencyclidine ................................................................................................................................................................... 7471 II
Cocaine ............................................................................................................................................................................ 9041 II
The company plans to import bulk applicants therefore, may file written material are not appropriate. 72 FR
active pharmaceutical controlled comments on or objections to the 3417, (January 25, 2007).
substances for distribution to its issuance of the proposed registration in SUPPLEMENTARY INFORMATION: The
customers for analytical purposes. accordance with 21 CFR 1301.34(a) on Attorney General has delegated his
In reference to drug codes 7360 and or before August 30, 2017. Such persons authority under the Controlled
7370, the company plans to import a may also file a written request for a Substances Act to the Administrator of
synthetic cannabidiol and a synthetic hearing on the application pursuant to the Drug Enforcement Administration
tetrahydrocannabinol. No other activity 21 CFR 1301.43 on or before August 30, (DEA), 28 CFR 0.100(b). Authority to
for these drug codes is authorized for 2017. exercise all necessary functions with
this registration. respect to the promulgation and
ADDRESSES: Written comments should
Dated: July 24, 2017. implementation of 21 CFR part 1301,
be sent to: Drug Enforcement incident to the registration of
Demetra Ashley,
Administration, Attention: DEA Federal manufacturers, distributors, dispensers,
Acting Assistant Administrator. Register Representative/DRW, 8701
[FR Doc. 2017–16064 Filed 7–28–17; 8:45 am]
importers, and exporters of controlled
Morrissette Drive, Springfield, Virginia substances (other than final orders in
BILLING CODE 4410–09–P 22152. All requests for hearing must be connection with suspension, denial, or
sent to: Drug Enforcement revocation of registration) has been
Administration, Attn: Administrator, redelegated to the Assistant
DEPARTMENT OF JUSTICE
8701 Morrissette Drive, Springfield, Administrator of the DEA Diversion
Drug Enforcement Administration Virginia 22152. All request for hearing Control Division (‘‘Assistant
should also be sent to: (1) Drug Administrator’’) pursuant to section 7 of
[Docket No. DEA–392] Enforcement Administration, Attn: 28 CFR part 0, appendix of subpart R.
Importer of Controlled Substances Hearing Clerk/LJ, 8701 Morrissette In accordance with 21 CFR
Application: Sigma-Aldrich Drive, Springfield, Virginia 22152; and 1301.34(a), this is notice that on January
International GMBH (2) Drug Enforcement Administration, 19, 2016, Sigma-Aldrich International
Attn: DEA Federal Register GMBH, Sigma Aldrich Co. LLC, 3500
ACTION: Notice of application. Representative/DRW, 8701 Morrissette Dekalb Street, Saint Louis, Missouri
Drive, Springfield, Virginia 22152. 63118 applied to be registered as an
DATES: Registered bulk manufacturers of Comments and requests for hearings on importer of the following basic classes
the affected basic classes, and applications to import narcotic raw of controlled substances:
sradovich on DSKBCFCHB2PROD with NOTICES
Controlled substance Drug code Schedule
Cathinone ........................................................................................................................................................................ 1235 I
Methcathinone ................................................................................................................................................................. 1237 I
Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I
N-Ethylamphetamine ....................................................................................................................................................... 1475 I
Aminorex .......................................................................................................................................................................... 1585 I
Gamma Hydroxybutyric Acid ........................................................................................................................................... 2010 I
VerDate Sep<11>2014 17:38 Jul 28, 2017 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\31JYN1.SGM 31JYN1](https://thefederalregister.org/doc/82_FR_35692/page/1.svg)
![35548 Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices
Controlled substance Drug code Schedule
Methaqualone .................................................................................................................................................................. 2565 I
Alpha-ethyltryptamine ...................................................................................................................................................... 7249 I
Ibogaine ........................................................................................................................................................................... 7260 I
Lysergic acid diethylamide .............................................................................................................................................. 7315 I
Marihuana ........................................................................................................................................................................ 7360 I
Tetrahydrocannabinols .................................................................................................................................................... 7370 I
Mescaline ......................................................................................................................................................................... 7381 I
4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 7391 I
4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 7392 I
4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 7395 I
2,5-Dimethoxyamphetamine ............................................................................................................................................ 7396 I
3,4-Methylenedioxyamphetamine .................................................................................................................................... 7400 I
N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7402 I
3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 7404 I
3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I
4-Methoxyamphetamine .................................................................................................................................................. 7411 I
Bufotenine ........................................................................................................................................................................ 7433 I
Diethyltryptamine ............................................................................................................................................................. 7434 I
Dimethyltryptamine .......................................................................................................................................................... 7435 I
Psilocybin ......................................................................................................................................................................... 7437 I
Psilocyn ........................................................................................................................................................................... 7438 I
1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 7470 I
N-Benzylpiperazine .......................................................................................................................................................... 7493 I
MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 7535 I
Butylone ........................................................................................................................................................................... 7541 I
Heroin .............................................................................................................................................................................. 9200 I
Normorphine .................................................................................................................................................................... 9313 I
Etonitazene ...................................................................................................................................................................... 9624 I
Amobarbital ...................................................................................................................................................................... 2125 II
Pentobarbital .................................................................................................................................................................... 2270 II
Secobarbital ..................................................................................................................................................................... 2315 II
Glutethimide ..................................................................................................................................................................... 2550 II
Nabilone ........................................................................................................................................................................... 7379 II
Phencyclidine ................................................................................................................................................................... 7471 II
Diphenoxylate .................................................................................................................................................................. 9170 II
Ecgonine .......................................................................................................................................................................... 9180 II
Ethylmorphine .................................................................................................................................................................. 9190 II
Levorphanol ..................................................................................................................................................................... 9220 II
Meperidine ....................................................................................................................................................................... 9230 II
Thebaine .......................................................................................................................................................................... 9333 II
Opium, powdered ............................................................................................................................................................ 9639 II
Levo-alphacetylmethadol ................................................................................................................................................. 9648 II
The company plans to import the SUMMARY: The Department of Labor 34553, correct the email address to read:
listed controlled substances for sale to published a document in the Federal Linton.Natalie.S@dol.gov.
research facilities for drug testing and Register of July 25, 2017 (82 FR 34553),
analysis. Byron Zuidema,
concerning requests for nominations for
the task force on apprenticeship Deputy Assistant Secretary for the
Dated: July 24, 2017.
Employment and Training Administration.
Demetra Ashley, expansion. The document contained an
[FR Doc. 2017–16062 Filed 7–28–17; 8:45 am]
Acting Assistant Administrator. incorrect email address in the FOR
FURTHER INFORMATION CONTACT section. BILLING CODE 4510–FR–P
[FR Doc. 2017–16059 Filed 7–28–17; 8:45 am]
BILLING CODE 4410–09–P FOR FURTHER INFORMATION CONTACT:
Please contact Ms. Natalie S. Linton, DEPARTMENT OF LABOR
Program Analyst, Employment and
Training Administration, Office of Office of the Secretary
DEPARTMENT OF LABOR Apprenticeship, at Linton.Natalie.S@
dol.gov, telephone (202) 693–3592 (this Agency Information Collection
Employment and Training Activities; Submission for OMB
Administration is not a toll-free number).
Review; Comment Request; Electric
Correction Power Generation, Transmission, and
Nominations for the Task Force on
Distribution Standard for Construction
sradovich on DSKBCFCHB2PROD with NOTICES
Apprenticeship Expansion; Correction In the Federal Register of July 25,
and General Industry and Electrical
2017, in FR Doc. 2017–15682, in the FOR
AGENCY:Employment and Training Protective Equipment for Construction
FURTHER INFORMATION CONTACT section
Administration, Labor. and General Industry
located in the third column of page
ACTION:Solicitation of Nominations to
ACTION:Notice of availability; request
Serve on the Task Force on
Apprenticeship Expansion. for comments.
VerDate Sep<11>2014 17:38 Jul 28, 2017 Jkt 241001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\31JYN1.SGM 31JYN1](https://thefederalregister.org/doc/82_FR_35692/page/2.svg)
Document Created: 2017-07-29 00:21:19
Document Modified: 2017-07-29 00:21:19
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 30, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 30, 2017. | |
| FR Citation | 82 FR 35547 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR